Stockreport

XORTX Appoints Lonza for GMP Manufacturing and Formulation of XRx-101 (Oxypurinol) for Coronavirus / COVID-19 Clinical Trials [Canadian Business Journal (Canada)]

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report
PDF CALGARY, Alberta, April 30, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“CompanyThe launch of Oxypurinol manufacturing for both the coronavirus / COVID-19 (XRx-101) [Read more]